Effects of Short-Term Human Albumin Infusion for the Prevention and Treatment of Hyponatremia in Patients with Liver Cirrhosis

被引:3
|
作者
Bai, Zhaohui [1 ,2 ]
Xu, Wentao [1 ,2 ]
Chai, Lu [1 ,2 ]
Zheng, Xiaojie [1 ]
Mendez-Sanchez, Nahum [3 ]
Philips, Cyriac Abby [4 ]
Cheng, Gang [2 ]
Qi, Xingshun [1 ,2 ]
机构
[1] Gen Hosp Northern Theater Command, Dept Gastroenterol, Liver Cirrhosis Study Grp, Shenyang 110840, Peoples R China
[2] Shenyang Pharmaceut Univ, NMPA Key Lab Res & Evaluat Drug Regulatory Techno, Shenyang 110016, Peoples R China
[3] Univ Nacl Autonoma Mexico, Med Sur Clin, Mexico City 14050, DF, Mexico
[4] Rajagiri Hosp, Ctr Excellence GI Sci, Liver Inst, Clin & Translat Hepatol, Aluva 683112, India
关键词
liver cirrhosis; hyponatremia; human albumin; prevention; treatment; QUALITY-OF-LIFE; SYSTEMIC INFLAMMATION; ASCITES; MANAGEMENT; MORTALITY; COMPLICATIONS; ASSOCIATION; GUIDELINES;
D O I
10.3390/jcm12010107
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Human albumin (HA) infusion is potentially effective for the management of hyponatremia in liver cirrhosis, but the current evidence is very limited. Methods: In this retrospective study, 2414 cirrhotic patients who were consecutively admitted to our hospital between January 2010 and June 2014 were included in the Hospitalization outcome cohort, and 339 cirrhotic patients without malignancy who were consecutively admitted to our department between December 2014 and April 2021 were included in the Long-term outcome cohort. The development and improvement of hyponatremia were compared between patients who received HA infusion during hospitalizations and did not. Logistic and Cox regression analyses were performed to evaluate the association of development and improvement of hyponatremia during hospitalizations with the outcomes. Odds ratios (ORs) and hazard ratios (HRs) were calculated. Results: In the two cohorts, HA infusion significantly decreased the incidence of hyponatremia and increased the rate of improvement of hyponatremia in cirrhotic patients during hospitalizations. In the Hospitalization outcome cohort, the development of hyponatremia during hospitalizations was significantly associated with increased in-hospital mortality (OR = 2.493, p < 0.001), and the improvement of hyponatremia during hospitalizations was significantly associated with decreased in-hospital mortality (OR = 0.599, p = 0.014). In the Long-term outcome cohort, the development of hyponatremia during hospitalizations was significantly associated with decreased long-term survival (HR = 0.400, p < 0.001), and the improvement of hyponatremia during hospitalizations was not significantly associated with long-term survival (HR = 1.085, p = 0.813). Conclusions: HA infusion can effectively prevent the development of hyponatremia and improve hyponatremia in cirrhotic patients during hospitalizations, which may influence the patients' outcomes.
引用
收藏
页数:17
相关论文
共 50 条
  • [31] Short-term mortality in patients with cirrhosis of the liver and acute kidney injury: A prospective observational study
    Uday Kumar
    Ravikant Kumar
    Sanjeev Kumar Jha
    Ashish Kumar Jha
    Vishwa Mohan Dayal
    Amarendra Kumar
    Indian Journal of Gastroenterology, 2020, 39 : 457 - 464
  • [32] Esophagectomy in patients with liver cirrhosis: systematic review and meta-analysis of short-term outcomes
    Sozzi, Andrea
    Aiolfi, Alberto
    Bonitta, Gianluca
    Bona, Davide
    Bonavina, Luigi
    Biondi, Antonio
    Rausa, Emanuele
    Simic, Aleksandar
    Skrobic, Ognjan
    Popa, Calin
    Schlanger, Diana
    UPDATES IN SURGERY, 2025, 77 (01) : 143 - 152
  • [33] A Prospective Study of Prevalence and Impact of Sarcopenia on Short-term Mortality in Hospitalized Patients with Liver Cirrhosis
    Kenchappa, Surakshith Thyloor
    Sharma, Samarth
    Kumar, Mandhir
    Ghuman, Samarjit S.
    Arora, Anil
    Ranjan, Piyush
    JOURNAL OF CLINICAL AND EXPERIMENTAL HEPATOLOGY, 2023, 13 (06) : 946 - 954
  • [34] POSTPRANDIAL VASCULAR-RESPONSE IN PATIENTS WITH CIRRHOSIS - SHORT-TERM EFFECTS OF PROPRANOLOL ADMINISTRATION
    ALVAREZ, D
    MIGUEZ, C
    PODESTA, A
    TERG, R
    MALO, AS
    BANDI, JC
    SANCHEZ, S
    MASTAI, R
    DIGESTIVE DISEASES AND SCIENCES, 1994, 39 (06) : 1288 - 1293
  • [35] THE EFFECTS OF SHORT-TERM LYMPHAPHERESIS IN PATIENTS WITH PRECIRRHOTIC PRIMARY BILIARY-CIRRHOSIS (PBC)
    KENICK, S
    KARSH, J
    PRCHAL, J
    KATZ, M
    JOTHY, S
    MISHKIN, S
    HEPATOLOGY, 1984, 4 (05) : 1090 - 1090
  • [36] COMPARISON OF THE SHORT-TERM EFFECTS OF MEPINDOLOL AND PROPRANOLOL ON SPLANCHNIC AND SYSTEMIC HEMODYNAMICS IN PATIENTS WITH CIRRHOSIS
    BRAILLON, A
    CALES, P
    LEBREC, D
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY RESEARCH, 1985, 5 (04) : 223 - 228
  • [37] EFFECT OF SHORT-TERM FASTING ON PLASMA TRYPTOPHAN IN LIVER-CIRRHOSIS
    ZENEROLI, ML
    CREMONINI, C
    LICARI, F
    PINELLI, G
    GOLLINI, C
    PRANZINI, L
    VENTURA, E
    ITALIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 1981, 13 (03): : 186 - 189
  • [38] Serum glycated albumin levels reflect short-term liver damage
    Uyama, Hirokazu
    Kasayama, Soji
    Koga, Masafumi
    Nakamura, Hideji
    Hiramatsu, Naoki
    Hayashi, Norio
    GASTROENTEROLOGY, 2007, 132 (04) : A801 - A801
  • [39] The metabolic and immunologic effects of short-term thalidomide treatment of patients infected with the human immunodeficiency virus
    Haslett, P
    Hempstead, M
    Seidman, C
    Diakun, J
    Vasquez, D
    Freedman, VH
    Kaplan, G
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 1997, 13 (12) : 1047 - 1054
  • [40] Long-term albumin treatment in patients with cirrhosis and ascites
    Caraceni, Paolo
    O'Brien, Alastair
    Gines, Pere
    JOURNAL OF HEPATOLOGY, 2022, 76 (06) : 1306 - 1317